These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4086197)
61. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors. de Paulis T; Janowsky A; Kessler RM; Clanton JA; Smith HE J Med Chem; 1988 Oct; 31(10):2027-33. PubMed ID: 3172140 [TBL] [Abstract][Full Text] [Related]
62. IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Zhuang ZP; Kung MP; Hou C; Plössl K; Skovronsky D; Gur TL; Trojanowski JQ; Lee VM; Kung HF Nucl Med Biol; 2001 Nov; 28(8):887-94. PubMed ID: 11711307 [TBL] [Abstract][Full Text] [Related]
63. Imaging benzodiazepine receptors in the human brain by single photon emission computed tomography (SPECT). Höll K; Deisenhammer E; Dauth J; Carmann H; Schubiger PA Int J Rad Appl Instrum B; 1989; 16(8):759-63. PubMed ID: 2559905 [TBL] [Abstract][Full Text] [Related]
64. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand. Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305 [TBL] [Abstract][Full Text] [Related]
65. Probes for narcotic receptor mediated phenomena. 18. Epimeric 6 alpha- and 6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinans as potential ligands for opioid receptor single photon emission computed tomography: synthesis, evaluation, and radiochemistry of [125I]-6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinan. de Costa BR; Iadarola MJ; Rothman RB; Berman KF; George C; Newman AH; Mahboubi A; Jacobson AE; Rice KC J Med Chem; 1992 Jul; 35(15):2826-35. PubMed ID: 1322988 [TBL] [Abstract][Full Text] [Related]
66. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease. Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502 [TBL] [Abstract][Full Text] [Related]
67. [(18)F]-labeled 2-methoxyphenylpiperazine derivative as a potential brain positron emission tomography imaging agent. Mou T; Yang W; Peng C; Zhang X; Ma Y Appl Radiat Isot; 2009 Nov; 67(11):2013-8. PubMed ID: 19679486 [TBL] [Abstract][Full Text] [Related]
68. Potential tumor- or organ-imaging agents. 29. Radioiodinated esters and amides of 20-hydroxy- and 20-aminopregn-5-en-3 beta-ols. Haradahira T; Schwendner SW; Kojima M; Counsell RE J Med Chem; 1989 Mar; 32(3):609-12. PubMed ID: 2918507 [TBL] [Abstract][Full Text] [Related]
69. Potential tumor or organ-imaging agents. 30. Radioiodinated phospholipid ethers. Meyer KL; Schwendner SW; Counsell RE J Med Chem; 1989 Sep; 32(9):2142-7. PubMed ID: 2769685 [TBL] [Abstract][Full Text] [Related]
70. Evaluation of N-alkyl derivatives of radioiodinated spiperone as radioligands for in vivo dopamine D2 receptor studies: effects of lipophilicity and receptor affinity on the in vivo biodistribution. Saji H; Tokui T; Nakatsuka I; Saiga A; Magata Y; Shiba K; Yoshitake A; Yokoyama A Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):165-9. PubMed ID: 1576667 [TBL] [Abstract][Full Text] [Related]
71. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors. Turolla EA; Matarrese M; Belloli S; Moresco RM; Simonelli P; Todde S; Fazio F; Magni F; Kienle MG; Leopoldo M; Berardi F; Colabufo NA; Lacivita E; Perrone R J Med Chem; 2005 Nov; 48(22):7018-23. PubMed ID: 16250661 [TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonist. Zea-Ponce Y; Kegeles LS; Guo N; Raskin L; Bakthavachalam V; Laruelle M Nucl Med Biol; 2002 Jul; 29(5):575-83. PubMed ID: 12088728 [TBL] [Abstract][Full Text] [Related]
73. Preparation and biodistribution of [125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. Kung HF; Guo YZ; Billings J; Xu X; Mach RH; Blau M; Ackerhalt RE Int J Rad Appl Instrum B; 1988; 15(2):195-201. PubMed ID: 2966782 [TBL] [Abstract][Full Text] [Related]
74. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of dopamine D2 receptors. Preparation of 125I-IBZM and its biodistribution and kinetic properties]. Matsumura K; Toyama H; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S Kaku Igaku; 1994 May; 31(5):513-9. PubMed ID: 8028224 [TBL] [Abstract][Full Text] [Related]
75. Comparative radiolabeling and distribution of a tumour-directed monoclonal antibody. Turner CJ; Sykes TR; Longenecker BM; Noujaim AA Int J Rad Appl Instrum B; 1988; 15(6):701-6. PubMed ID: 3251903 [TBL] [Abstract][Full Text] [Related]
76. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621 [TBL] [Abstract][Full Text] [Related]
77. Radioiododestannylation: preparation and evaluation of radioiodinated thienyl alcohols. Hanson RN; Franke L; Lee SH; Seitz DE Int J Rad Appl Instrum A; 1987; 38(8):641-5. PubMed ID: 2822622 [TBL] [Abstract][Full Text] [Related]
78. Development of I-123-labeled amines for brain studies: localization of I-123 iodophenylalkyl amines in rat brain. Winchell HS; Baldwin RM; Lin TH J Nucl Med; 1980 Oct; 21(10):940-6. PubMed ID: 7420195 [No Abstract] [Full Text] [Related]
79. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain. de Paulis T Curr Pharm Des; 2003; 9(8):673-96. PubMed ID: 12570798 [TBL] [Abstract][Full Text] [Related]
80. In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent. Akhter N; Shiba K; Ogawa K; Kinuya S; Nakajima K; Mori H Nucl Med Biol; 2007 Aug; 34(6):697-702. PubMed ID: 17707810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]